Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.47 USD | -1.04% | -11.36% | -50.37% |
05-08 | Baird Adjusts Price Target on EyePoint Pharmaceuticals to $38 From $46, Keeps Outperform Rating | MT |
05-08 | Earnings Flash (EYPT) EYEPOINT PHARMACEUTICALS Posts Q1 Revenue $11.7M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.37% | 597M | |
+37.74% | 723B | |
+34.77% | 595B | |
-2.07% | 369B | |
+20.25% | 332B | |
+2.99% | 282B | |
+17.15% | 244B | |
+10.07% | 208B | |
-4.17% | 205B | |
+7.43% | 166B |
- Stock Market
- Equities
- EYPT Stock
- News EyePoint Pharmaceuticals, Inc.
- EyePoint Pharmaceuticals Names Jay Duker CEO; Shares Climb